Fasting as a Potential Strategy to Combat Cancer: Doctors Explore ‘Starving Cancer’ for Better Treatment Outcomes

Doctors are exploring the potential of fasting as a complementary strategy to slow cancer growth and enhance the effectiveness of chemotherapy. During a recent episode of Dr. Mark Hyman’s podcast, Dr. Jason Fung, a Canadian physician and researcher, explained how fasting could shift the body’s metabolic state, placing cells into a ‘repair mode’ rather than a ‘growth mode.’ This concept, he argued, is critical for cancer patients because chemotherapy targets rapidly dividing cells, which include both healthy tissues and cancer cells. By reducing nutrient availability through fasting, the body may prioritize cellular repair over proliferation, potentially shielding healthy cells from treatment-induced damage while making cancer cells more susceptible to chemotherapy.

Fung compared this biological process to a car engine, noting that continuous high-speed operation without maintenance leads to ‘burnout.’ Similarly, the body’s cells require periodic ‘pit stops’ to reset their metabolic pathways. He emphasized that while growth is essential for normal bodily functions, excessive growth—such as in cancer—can be detrimental. Fasting, he explained, interrupts this growth cycle, allowing the body to focus on repairing damaged cells and maintaining long-term health. This approach could mitigate common chemotherapy side effects like hair loss and nausea, which result from the treatment’s impact on rapidly dividing cells in the gastrointestinal tract and hair follicles.

Dr. Frank Dumont, an internal medicine physician specializing in metabolic health, corroborated these findings while cautioning against over-reliance on fasting. Dumont highlighted that adjusting macronutrient intake—such as reducing carbohydrate consumption—can achieve similar metabolic benefits without the need for fasting. He noted that lowering glucose and insulin levels can reduce inflammation and improve metabolic function, creating an environment less favorable for cancer cell growth. Dumont emphasized individualized approaches, stating that patients should choose strategies—whether fasting, dietary changes, or other interventions—that align with their lifestyle and tolerance levels.

The research underscores the complex interplay between nutrition, metabolism, and cancer biology. Dumont explained that some cancer cells rely heavily on glucose for energy, making them vulnerable to metabolic shifts that limit glucose availability. Conversely, other cancers may utilize alternative energy sources like ketones, requiring tailored strategies to ‘starve’ them effectively. The consensus among experts is that integrating lifestyle modifications with traditional treatments can enhance patient outcomes, offering a holistic approach to cancer care that prioritizes both cellular health and systemic balance.